Further delineation of the KAT6B molecular and phenotypic spectrum

Tamsin Gannon, Rahat Perveen, Hélene Schlecht, Simon Ramsden, Beverley Anderson, Bronwyn Kerr, Ruth Day, Siddharth Banka, Mohnish Suri, Siren Berland, Michael Gabbett, Alan Ma, Stan Lyonnet, Valerie Cormier-Daire, Rüstem Yilmaz, Guntram Borck, Dagmar Wieczorek, Britt Marie Anderlid, Sarah Smithson, Julie VogtHeather Moore-Barton, Pelin Ozlem Simsek-Kiper, Isabelle Maystadt, Anne Destrée, Jessica Bucher, Brad Angle, Shehla Mohammed, Emma Wakeling, Sue Price, Amihood Singer, Yves Sznajer, Annick Toutain, Damien Haye, Ruth Newbury-Ecob, Melanie Fradin, Julie McGaughran, Beyhan Tuysuz, Mark Tein, Katelijne Bouman, Tabib Dabir, Jenneke Van Den Ende, Ho Ming Luk, Daniela T. Pilz, Jacqueline Eason, Sally Davies, Willie Reardon, Livia Garavelli, Orsetta Zuffardi, Koen Devriendt, Ruth Armstrong

Research output: Contribution to journalArticle

31 Scopus citations

Abstract

KAT6B sequence variants have been identified previously in both patients with the Say-Barber-Biesecker type of blepharophimosis mental retardation syndromes (SBBS) and in the more severe genitopatellar syndrome (GPS). We report on the findings in a previously unreported group of 57 individuals with suggestive features of SBBS or GPS. Likely causative variants have been identified in 34/57 patients and were commonly located in the terminal exons of KAT6B. Of those where parental samples could be tested, all occurred de novo. Thirty out of thirty-four had truncating variants, one had a missense variant and the remaining three had the same synonymous change predicted to affect splicing. Variants in GPS tended to occur more proximally to those in SBBS patients, and genotype/phenotype analysis demonstrated significant clinical overlap between SBBS and GPS. The de novo synonymous change seen in three patients with features of SBBS occurred more proximally in exon 16. Statistical analysis of clinical features demonstrated that KAT6B variant-positive patients were more likely to display hypotonia, feeding difficulties, long thumbs/great toes and dental, thyroid and patella abnormalities than KAT6B variant-negative patients. The few reported patients with KAT6B haploinsufficiency had a much milder phenotype, though with some features overlapping those of SBBS. We report the findings in a previously unreported patient with a deletion of the KAT6B gene to further delineate the haploinsufficiency phenotype. The molecular mechanisms giving rise to the SBBS and GPS phenotypes are discussed.

Original languageEnglish (US)
Pages (from-to)1165-1170
Number of pages6
JournalEuropean Journal of Human Genetics
Volume23
Issue number9
DOIs
StatePublished - Sep 14 2015

ASJC Scopus subject areas

  • Genetics
  • Genetics(clinical)

Fingerprint Dive into the research topics of 'Further delineation of the KAT6B molecular and phenotypic spectrum'. Together they form a unique fingerprint.

  • Cite this

    Gannon, T., Perveen, R., Schlecht, H., Ramsden, S., Anderson, B., Kerr, B., Day, R., Banka, S., Suri, M., Berland, S., Gabbett, M., Ma, A., Lyonnet, S., Cormier-Daire, V., Yilmaz, R., Borck, G., Wieczorek, D., Anderlid, B. M., Smithson, S., ... Armstrong, R. (2015). Further delineation of the KAT6B molecular and phenotypic spectrum. European Journal of Human Genetics, 23(9), 1165-1170. https://doi.org/10.1038/ejhg.2014.248